Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 21.55
(-0.23%)
CNY 21.55
(-0.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 382.07 Million | 360.27 Million | 360.57 Million | 256.22 Million | 232.92 Million | 206.45 Million |
| Net Income | 295.52 Million | 335.72 Million | 326.28 Million | 269.72 Million | 292.62 Million | 231.86 Million |
| Depreciation & Amortization | 38.45 Million | 26.07 Million | 25.06 Million | 15.02 Million | 10.36 Million | 7.25 Million |
| Deferred income taxes | -38.08 Thousand | 516.71 Thousand | -970.81 Thousand | -762.65 Thousand | -1.69 Million | -162 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 47.41 Million | -47.24 Million | 11.49 Million | -26.36 Million | -69.53 Million | -26.18 Million |
| Other non-cash items | 685.26 Thousand | 45.71 Million | -2.27 Million | -2.16 Million | -524.84 Thousand | -6.48 Million |
| Investing Cash Flow | -191.87 Million | -118.19 Million | -212.3 Million | -90.73 Million | -606.93 Million | 132.39 Million |
| Investments in PPE | -209.15 Million | -188.73 Million | -122.15 Million | -70.15 Million | -99.82 Million | -57.75 Million |
| Acquisitions | 2972.15 | 215 Thousand | - | 470.00 | 40.00 | - |
| Investment purchases | -600.06 Million | -484.39 Million | -843.05 Million | -363 Million | -847 Million | -561 Million |
| Sales/Maturities of investments | 612.24 Million | 517.58 Million | 742.69 Million | 337.36 Million | 328.11 Million | 753.27 Million |
| Other Investing Activities | 5.1 Million | 37.14 Million | 10.2 Million | 5.05 Million | 11.78 Million | -2.13 Million |
| Financing Cash Flow | -23.41 Million | -111.02 Million | -89.58 Million | -94.24 Million | 63.78 Million | -64.64 Million |
| Debt repayment | -20 Million | -5.78 Million | -5.8 Million | - | - | - |
| Dividends payments | -104.71 Million | -105.24 Million | -83.77 Million | -94.24 Million | -72.72 Million | -64.64 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 77.21 Million | -0.14 | -0.80 | - | 136.5 Million | - |
| Accounts receivables | 66 Million | -30.94 Million | -34.58 Million | -12.17 Million | -52.95 Million | -36.63 Million |
| Accounts payables | -9.16 Million | -20.91 Million | 52.46 Million | -1.91 Million | -1.54 Million | 14.26 Million |
| Inventory | -9.38 Million | 4.1 Million | -5.41 Million | -11.51 Million | -13.34 Million | -3.64 Million |
| Other working capital | -38.08 Thousand | 516.71 Thousand | -970.82 Thousand | -762.65 Thousand | -1.69 Million | -22.53 Million |
| Cash at beginning of period | 410.79 Million | 279.7 Million | 221.03 Million | 149.82 Million | 460.04 Million | 185.81 Million |
| Cash at end of period | 577.58 Million | 410.79 Million | 279.7 Million | 221.03 Million | 149.82 Million | 460.04 Million |
| Capital Expenditure | -209.15 Million | -188.73 Million | -122.15 Million | -70.15 Million | -99.82 Million | -57.75 Million |
| Effect of forex changes on cash | 6738.75 | 23.09 Thousand | -12.69 Thousand | -29.5 Thousand | 6605.70 | 25.06 Thousand |
| Net cash flow / Change in cash | 166.79 Million | 131.08 Million | 58.67 Million | 71.2 Million | -310.21 Million | 274.22 Million |
| Free Cash Flow | 172.91 Million | 171.54 Million | 238.41 Million | 186.06 Million | 133.09 Million | 148.7 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 123.02 Million | 72.02 Million | 77.2 Million | 40.03 Million | 295.52 Million | 121.54 Million |
| Depreciation & Amortization | - | 12.87 Million | 12.87 Million | 11.62 Million | 38.45 Million | -15.55 Million |
| Deferred income taxes | - | - | - | - | -38.08 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -64.73 Million | - | 56.61 Million | 47.41 Million | -26.27 Million |
| Other non-cash items | -63.61 Million | 266.71 Thousand | -33.36 Million | 22.45 Million | 685.26 Thousand | 7.59 Million |
| Investing Cash Flow | -316.6 Million | -203.77 Million | -25.19 Million | -247.93 Million | -191.87 Million | 76.23 Million |
| Investments in PPE | -24.81 Million | -21.45 Million | -51.8 Million | -27.42 Million | -209.15 Million | -48.81 Million |
| Acquisitions | 15 Thousand | - | - | - | 2972.15 | - |
| Investment purchases | -420 Million | -191.5 Million | - | -281.06 Million | -600.06 Million | -82 Million |
| Sales/Maturities of investments | 25.5 Million | 109 Million | 30 Million | 50 Million | 612.24 Million | 208 Million |
| Other Investing Activities | 102.71 Million | -99.81 Million | -3.39 Million | 10.55 Million | 5.1 Million | -956.96 Thousand |
| Financing Cash Flow | -110.85 Million | -10.14 Million | 666.14 Thousand | 2.55 Million | -23.41 Million | -127.23 Million |
| Debt repayment | -12.2 Million | -7.33 Million | -2.76 Million | -4.99 Million | -20 Million | -20 Million |
| Dividends payments | -96.94 Million | -56.35 Thousand | -443.79 Thousand | -682.81 Thousand | -104.71 Million | -104.74 Million |
| Common Stock Repurchased | - | - | - | - | - | -85.78 Million |
| Common Stock Issuance | - | - | - | - | - | 105.78 Million |
| Other Financing Activities | -1.7 Million | 1.59 Million | -2.09 Million | -1.74 Million | 77.21 Million | -22.49 Million |
| Accounts receivables | - | -62.01 Million | - | 66 Million | 66 Million | -29.77 Million |
| Accounts payables | - | - | - | - | -9.16 Million | - |
| Inventory | - | -2.71 Million | - | -9.38 Million | -9.38 Million | 3.49 Million |
| Other working capital | - | - | - | - | -38.08 Thousand | - |
| Cash at beginning of period | 442.4 Million | 1.19 Billion | 1.06 Billion | 692.23 Million | 410.79 Million | 655.93 Million |
| Cash at end of period | 72.85 Million | 1.22 Billion | 1.19 Billion | 577.58 Million | 577.58 Million | 692.23 Million |
| Capital Expenditure | -24.81 Million | -21.45 Million | -51.8 Million | -27.42 Million | -209.15 Million | -48.81 Million |
| Effect of forex changes on cash | -4929.90 | 2412.93 | 218.02 | -5080.34 | 6738.75 | -2118.96 |
| Net cash flow / Change in cash | -369.54 Million | 27.86 Million | 127.88 Million | -114.65 Million | 166.79 Million | 36.3 Million |
| Free Cash Flow | 34.59 Million | 37.96 Million | -7.95 Million | 103.3 Million | 172.91 Million | 38.49 Million |
ALG
CWBK
2670
1183
SLQT
4919